CYTH — Cyclo Therapeutics Share News
0.000.00%
Last trade - 00:00- $23.04m
- $34.29m
- $1.08m
Cyclo Therapeutics Inc reports results for the quarter ended in March - Earnings Summary
Cyclo Therapeutics Inc expected to post a loss of 20 cents a share - Earnings Preview
Brief: Cyclo Therapeutics Says It Received A Notice From Nasdaq Informing That Company Is In Compliance With All Applicable Nasdaq Listing Standards
U.S. STOCKS ON THE MOVE-Boston Scientific, Rockwell Medical, Visa
U.S. STOCKS ON THE MOVE-Fox Corp, Cisco Systems, Darden Restaurants
Applied Molecular rises on merger deal with Cyclo Therapeutics
Brief: Cyclo Therapeutics And Applied Molecular Transport Enter Into A Definitive Merger Agreement
Cyclo Therapeutics Inc reports results for the quarter ended in June - Earnings Summary
Cyclo Therapeutics Inc expected to post a loss of 44 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Precision Optics, Tesla, airline stocks
Cyclo Therapeutics rises on European patent for Alzheimer's disease drug
Brief: Cyclo Therapeutics Announces Execution Of Definitive Agreement With Rafael Holdings Providing For $5.0 Million Of Additional Funding Via A Private Placement
Brief: Cyclo Therapeutics - On May 15, Co Got Letter From Nasdaq Stating That Co Was Not In Compliance With Nasdaq Listing Rule
Cyclo Therapeutics Inc reports results for the quarter ended in March - Earnings Summary
Brief: Cyclo Therapeutics Provides Business Update And Reports First Quarter 2023 Financial Results
Cyclo Therapeutics Inc expected to post a loss of 42 cents a share - Earnings Preview
Brief: Cyclo Therapeutics Says In Discussions With Potential Strategic Parties Including For Deal
Brief: Cyclo Therapeutics Provides Business Update And Reports Full Year 2022 Financial Results
Cyclo Therapeutics Inc expected to post a loss of 25 cents a share - Earnings Preview